Next Article in Journal
Metastatic Multifocal Malignant Peripheral Nerve Sheath Tumour in the Cervicothoracic Spinal Cord of a Dog Initially Mimicking Meningomyelitis
Next Article in Special Issue
Characterization of the Blood Microbiome and Comparison with the Fecal Microbiome in Healthy Dogs and Dogs with Gastrointestinal Disease
Previous Article in Journal
The Importance of the Slaughterhouse in Surveilling Animal and Public Health: A Systematic Review
Previous Article in Special Issue
The Anticoccidial Effect of Alcoholic Vitis vinifera Leaf Extracts on Eimeria papillate Oocysts Isolated in Mice In Vitro and In Vivo
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Veterinary Sciences
Volume 10
Issue 2
10.3390/vetsci10020169
vetsci-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Short Term Effect of Ivermectin on the Bacterial Microbiota from Fecal Samples in Chinchillas (Chinchilla lanigera)

by
Xinyi Ma
1,†,
Jing Li
1,2,†,
Luo Yang
1,
Haoqian Liu
1,
Yiping Zhu
1,
Honglin Ren
1,
Feng Yu
1,2,* and
Bo Liu
1,2,*
1
Department of Clinical Veterinary Medicine, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China
2
China Agricultural University Veterinary Teaching Hospital (Beijing Zhongnongda Veterinary Hospital Co., Ltd.), Beijing 100193, China
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Vet. Sci. 2023, 10(2), 169; https://doi.org/10.3390/vetsci10020169
Submission received: 9 January 2023 / Revised: 10 February 2023 / Accepted: 12 February 2023 / Published: 20 February 2023
(This article belongs to the Special Issue The Effects of Microbiota on Animal Health)
Browse Figures
Versions Notes

Abstract

:

Simple Summary

For the first time we evaluated the effect of ivermectin treatment on the fecal bacterial microbiota of healthy chinchillas by 16S rRNA gene sequencing. Ten clinically healthy chinchillas were included in this study. Via comparing the difference between microbiota composition of fecal samples of the 10 chinchillas before and 14 days after ivermectin administration, we found out that there was no significant alteration in the abundance and diversity of fecal bacterial microbiota after ivermectin injection, and the relative abundance of some bacterial species changed without observed negative impact on chinchillas’ health. These results indicated single subcutaneous injection of ivermectin in therapeutic dose to healthy chinchillas had a mild impact on the fecal bacterial microbiota in short term and provided guidance for clinical ivermectin treatment in chinchillas.

Abstract

The gastrointestinal microbiota plays an important role in health of the host animals and the detrimental influence of pharmaceutical treatment on the fecal microbiota receives an increasing concern. The clinical use of ivermectin on chinchillas has not yet been evaluated. The purpose of our study was to assess the influence of ivermectin injection on the fecal bacterial microbiota of chinchillas. A with-in subject, before and after study was performed on 10 clinically healthy chinchillas during a 14-day period, all chinchillas received the same ivermectin treatment, and the microbiota from their fecal samples before and after administration were compared as two experimental groups. Fecal samples were collected on day 0 (before ivermectin administration) and day 14 (post ivermectin administration). Fecal bacterial microbiota was analyzed by bacterial 16S rRNA gene sequencing. No clinical abnormalities were observed post subcutaneous administration of ivermectin. No significant alteration was found in the abundance and diversity of fecal bacterial microbiota after treatment, but the dominant position of some bacterial species changed. In conclusion, ivermectin administration was associated with minimal alternations of the fecal bacterial microbiota in healthy chinchillas, and these changes had no observed negative effect on general health of chinchillas in short term.

1. Introduction

Chinchillas are non-ruminant herbivores that belong to Chinchillidae family, native to the Andes of South America. Although it is considered that wild chinchillas are almost extinct, domestic chinchillas descended from Chinchilla lanigera are often bred in fur farms because of their soft and fine furs or kept as companion exotic pets [1,2]. In chinchillas, Syphacia obvelata is occasionally seen, and ectoparasites such as Ctenocephalides spp., Lagidiophthirus spp., and Atricholaelaps chinchillae can be observed [3].
In recent years, more studies are focusing on the interaction between pharmaceuticals and gut microbiota, which can regulate the host metabolism and maintain as an important barrier for animals to prevent the colonization of pathogenic microorganisms [4,5]. Gut microbiota participates in the formation and breakdown of various compounds such as short chain fatty acids (SCFAs), organic acids, conjugated linoleic acid, phenolic compounds and so on, which play an important part in regulating metabolism, the immune system, and inflammatory response. Furthermore, via the regulation, gut microbial metabolites may affect the pathogenesis of a diverse range of diseases [5,6,7]. Thus, it is evident that changes in the gut microbiota have effects on the course of many diseases and affect host homeostasis and immune function [4,5,8].
Ivermectin is an antiparasitic, commonly used for controlling parasitic infestation in chinchillas by its oral or injectable formulation [3,9,10]. However, since it has antibacterial properties [11], the treatment of ivermectin may lead to the imbalance of gut microbiota, and that may promote the emergence and development of diseases [5,6,8]. A previous study found that combinative administration of fenbendazole and ivermectin tablets disturbed the homeostasis of gut microbiota and metabolism in Amur tiger [12]. One study on hookworm infected adolescents showed that combination treatment of tribendimidine and ivermectin triggered a re-composition of the gut microbiota [13].
At present, there is no report about the ivermectin effects on the fecal bacterial microbiota of chinchillas. Our study is the first to focus on the subcutaneous injection of ivermectin in chinchillas and explored its potential impacts on bacterial composition using 16S rRNA gene sequencing.

2. Materials and Methods

2.1. Animals

This study included 10 adult chinchillas (5 males and 5 females), ranging in age from 1–2 years, which belong to a commercial farm in Beijing, China. No animals participating in the study received any treatment prior to the experiment. Chinchillas were placed in individual cages, within a climate-controlled room temperature maintaining between 21 °C and 23 °C, and they were provided with a commercial pelleted diet (Mazuri® Chinchilla Diets, Land O’Lakes, Inc., Melrose, MN, USA) with fresh timothy hay and tap water ad libitum. All animals were clinically healthy based on normal physical examination and close observation of food intake and fecal output. The shape and color of all fecal pellets during the experiment were normal, and for fecal samples collected from the 10 chinchillas on day 0 (before ivermectin injection) and day 14 (14 days after ivermectin injection), no gastrointestinal parasites were found in fecal fresh smear and zinc sulfate floating test under microscopic examination. Our study was approved by the animal care and use committee of China Agricultural University and we obtained the informed consent statement from the breeder.

2.2. Study Design and Fecal Sample Collection

Within subjects, we performed a before and after study instead of a cross over study given that the necessary washout period of ivermectin in chinchillas is unknown. In this experiment, the 10 chinchillas were injected subcutaneously with ivermectin injection (Ivomec®, Merial, Ingelheim am Rhein, Germany, 1.0% w/v sterile solution, dilute 10 times by saline) 0.4 mg/kg on day 0.
Fresh fecal samples were collected on day 0 and day 14, divided into day 0 group and day 14 group, respectively. Chinchillas were placed individually into clean cages, and fecal pellets were collected upon evacuation. Following collection, these samples were transferred immediately into sterile cryogenic vials by sterile forceps and stored at −80 °C until microbiota analysis [14].

2.3. DNA Extraction and 16S rRNA Sequencing

Total bacterial genomic DNA was extracted by using a commercially available extraction kit (PowerFecal® DNA Isolation Kit, MO BIO Laboratories, Inc., Carlsbad, America) from fecal samples according to manufacturer’s instructions. To analyze the microbiota composition of bacterial communities in the fecal samples, the primer pairs from 338F (5′-ACTCTACGGAGCAGCA-3′) to 806R (5′-GACTACHVGGTWTCAT-3′) were used to amplify the hypervariable region V3 and V4 of bacterial 16S rRNA genes and the final products were sequenced by Illumina Novaseq6000 PE250 [15].

2.4. Statistical Analysis

To access the diversity of the gastrointestinal bacterial community (e.g., α-diversity), the number of observed operational taxonomic units (OTUs), the Chao 1 estimator and the ACE estimator assessed the richness of bacterial composition and represented the number of different taxa in both groups. By using USEARCH (v10.0), sequences with ≥97% similarity were assigned to the same OTUs and 0.005% of the number of sequences was used as the threshold to filter OTUs. In addition, the Shannon-wiener index and Simpson index were used for evaluating the abundance and evenness of samples, namely community diversity. The Chao 1 index, Ace index, Shannon index, and Simpson index were calculated by QIIME2 (v2021.4.0, Quantitative Insights Into Microbial Ecology 2).
To evaluate differences in overall bacterial microbiota composition between groups (i.e., β-diversity), it was measured by bray-curtis distance metric and visualized using Principal Coordinate Analysis (PCoA) plots to evaluate the similarity between two groups. Wilcoxon rank-sum test calculated the p-value of relative abundance difference to clarify whether the change was statistically significant, and the linear discriminant analysis effect size (LEfSe) figured out the significantly different biomarkers of the two groups.
A p-value of <0.05 was considered significant.

3. Results

3.1. Clinical Findings and Parasitic Examination

After administration of ivermectin, no chinchillas developed adverse reactions during the study. The appearance of feces was unchanged, being the same oval shape, dry and hard state. There was no loose stool or any clinical abnormalities. No parasites or eggs were found in fecal fresh smear and zinc sulfate floating test under microscopic examination before and after ivermectin treatment.

3.2. Microbiota Profile Analysis

The number of OTUs in day 0 group and day 14 group were 684 and 662, respectively, and 646 identical OTUs were shared between the two groups. The richness and composition of intestinal microbiota were measured by α-diversity indexes, which contain the Chao 1 index, ACE estimator, Shannon index, and Simpson index. There was no significant difference of the microbiota abundance between day 0 and day 14 with the result of Chao 1 index (p = 0.843), ACE index (p = 0.823), Shannon index (p = 0.464), and Simpson index (p = 0.580) (Figure 1).

3.3. Compositional Analysis

When comparing the taxonomic abundance of the two groups at the phylum level, the microbial community were similar before and after ivermectin administration. In both groups, Firmicutes was the most abundant phylum, followed by Bacteriodetes, Patescibacteria, Tenericutes, Actinobacteria, Proteobacteria, Elusimicrobia, Verrucomicrobia, Spirochaetes, and Cyanobacteria (Figure 2a). Firmicutes and Bacteriodetes were the main composition of bacterial phyla, which added up to 88.76–89.22%. Cyanobacteria was 0.29% on day 14, which decreased significantly compared to 0.73% on day 0 (p = 0.034).
For the genus level, 180 OTUs were identified, the most common bacterial genera were uncultured_bacterium_f_Muribaculaceae and uncultured_bacterium_f_Erysipelotrichaceae in both groups. The other common genera in the two groups were Ruminococcaceae_UCG-014, Bacteroides, Prevotellaceae_UCG-001, Ruminococcus_1, uncultured_bacterium_f_Lachnospiraceae and Prevotella_9 (Figure 2b). Higher levels were found in Bacteroides (10.264%), Prevotellaceae_UCG-001 (5.156%), Ruminococcus_1 (4.177%), and uncultured_bacterium_f_Lachnospiraceae (4.435%) on day 0, with no significant difference compared to day 14.
β-diversity was accessed by a PCoA. On the basis of Bray–Curtis, no statistic difference in microbial community composition between day 0 and day 14 was founded at phylum level.
The linear discriminant analysis (LDA) effect size was applied to compare the difference between two groups. At the genus or higher levels, there was significant difference (Figure 3) between the day 0 and day 14 groups (LDA score > 2, p < 0.05). The genus included in the specific biomarkers of the day 0 group was Rikenellaceae_RC9_gut_group, which also had the highest LDA scores. The rest of genera associated with the day 0 group were Lachnospiraceae_NK4A136_group, Methylobacterium, Angelakisella, and Oscillibacter. While Ruminococcaceae_UCG_013, Pediococcus, Eubacterium, Bacillus, and Catabacter were the genera most associated with the day 14 group.

4. Discussion

To our knowledge, this is the first study to assess the effect of ivermectin treatment on the fecal bacterial microbiota of chinchillas by 16S rRNA gene sequencing. Our pilot study only found minimal changes of fecal bacterial microbiota in chinchillas before and after ivermectin injection without significant difference in richness and diversity and no obvious clinical abnormalities were noticed.
The treatment of ivermectin did not change the main bacterial composition significantly at the phylum and genus level. According to previous research, Firmicutes, Bacteroidetes, Verrucomicrobia, Spirochaetes, and Proteobacteria were the main fecal microbiota in domestic herbivores, and the ratio of Firmicutes to Bacteroidetes was <2 in hindgut fermenters [16,17,18]. Our experimental result shared similarities that Firmicutes and Bacteroidetes dominated among these phyla and the ratio of them was <2 in chinchillas. Although the use of ivermectin did not alter the main phyla composition of fecal bacterial microbiota, the relative quantity and proportion of bacterial microorganisms in the two groups were still different in some ways.
At the phylum level, the significant change was decreased Cyanobacteria post ivermectin administration. Cyanobacteria exists widely in surrounding environment like marine and freshwater and has also been detected in the fecal bacteria communities of horses and volcano rabbit [19,20,21], which some similarity in hindgut fermenters. As a minor component of intestinal microflora, one study hypothesized that the Cyanobacteria overgrowth with production of neurotoxins had been related to the development of neurodegenerative diseases such as Equine Motor Neuron Disease [22]. Additionally, there is an overview showing that many diseases such as virus infection, neurodegeneration, gastrointestinal and metabolic diseases are associated with higher gut Cyanobacterial abundance [19]. Although Cyanobacteria are always associated with hazardous production and negative influence, there are potentially beneficial compounds produced by Cyanobacteria [23]. Besides, some studies also showed that cirrhosis and obesity were related to lower gut Cyanobacterial abundance [19]. According to these previous studies, further research is needed to clarify the correlation between Cyanobacterial abundance and animal health. Our study for the first time found Cyanobacteria was a main component in chinchilla fecal microbiota, and ivermectin administration was related to its decrease. Considering the double-edged effects of Cyanobacteria, its potential effects on chinchillas’ intestinal health deserve further study.
For the genus level, Uncultured_bacterium_f_Muribaculaceae was the most common genus, found in the rumen microbial community of sheep as well [24], being slightly more predominant on day 14 post ivermectin usage in this study. This bacterial genus could produce succinic acid as an important gluconeogenic intermediate and was helpful with polysaccharides degradation and metabolism [25]. Prevotellaceae_UCG-001, however, was more predominant on day 0. As a negative fermentation parameter [26], when combined with higher uncultured_bacterium_f_Muribaculaceae in day 14, suggesting it is not a negative change for production and fermentation [24]. Bacteroides participates in the utilization of plant polysaccharide in marine and terrestrial herbivores [16]. It was slightly decreased on day 14 after ivermectin injection, meaning ivermectin might pose a negative influence on the plant utilization.
LEfSe analysis showed that the relative abundance of some bacteria changed statistically after administration. Rikenellaceae_RC9_gut_group is included in Rikenellaceae family, which produces hydrogen and mediates suppression of proinflammatory cytokines, was found to be associated with day 0 [27]. Besides, this genus participates in degrading plant-derived polysaccharides, and its relative abundance is positively associated with dietary fiber content [28]. Oscillibacter is a common genus in herbivores and may assist in plant polysaccharide utilization [16], was identified on day 0. Some articles showed that Oscillibacter contained beneficial bacteria, of which the metabolites like butyric acid and alpha-linolenic acid can resist inflammation and protect intestinal mucosa [29,30]. Speculating effects of ivermectin on these genera may affect the intestinal microbiota balance and change the fiber metabolism, which reduces the protective function of normal microbiota.
Ruminococcaceae_UCG_013 is a genus in the Ruminococcaceae family, belongs to Firmicutes, and is most significantly associated with the day 14 group. This genus produces butyrate, promoting the differentiation of Treg cells which participate in enhancing the barrier integrity of epithelium and anti-inflammatory action, thus Ruminococcaceae_UCG_013 is beneficial to intestinal immune function and general health [31]. In addition, Ruminococcaceae_UCG_013 can help utilize or degrade indigestible fiber, such as cellulose and hemicellulose, and is an important genus for herbivores digestion [31,32]. Besides, Pediococcus, Eubacterium, and Bacillus were also related to day 14 significantly. Pediococcus is a genus of lactic acid bacteria, which are common intestinal microorganisms. This genus can be used as probiotics as Pediococcus strains can produce pediocin, an effective antilisterial bacteriocin. It has been proven that some Pediococcus strains isolated from horse feces have great inhibition on Escherichia coli, Salmonella enteritidis, Listeria monocytogenes, and Staphylococcus aureus [33]. Eubacterium is a common butyrate-producing genus in herbivore intestine [16], positively related to the level of SCFAs, which are beneficial to intestinal health of animals and play a key role in colon motility, immune regulation and intestinal inflammation inhibition [34,35]. Bacillus belongs to Firmicutes, plays a significant role in animal immunity and antibacterial ability. It is often used as probiotics and has various related commercially available products [36,37,38]. A Bacillus strain isolated from donkey cecum showed good ability on inhibiting the development of pathogens [38].
In chinchillas, gastrointestinal disorders are common and are associated with dysbacteriosis [39]. Syphacia obvelata is an internal parasite occasionally observed in chinchillas and ivermectin is a clinical treatment for the disease. However, ivermectin has antibacterial properties, which may lead to gastrointestinal disease by causing dysbacteriosis [8,11], so figuring out the influence of ivermectin on the gut microbiota of chinchillas is important.
Our study suggested that single subcutaneous injection of ivermectin in therapeutic dose had mild impact on the fecal microbiota of healthy chinchillas, and the result can provide guidance for clinical roundworms treatment in chinchillas. Considering one of the limitations of this study is the before-after study design, additional studies employing a non-treated control, or an interrupted time series analysis would be needed to validate our findings.

5. Conclusions

Overall, single subcutaneous injection of ivermectin had a mild impact on the fecal microbiota in healthy chinchilla and no significant passive influence was observed on general health in short term. Of the phylum, Cyanobacteria decreased significantly after treatment. Of the genera, Rikenellaceae_RC9_gut_group, Lachnospiraceae_NK4A136_group, Methylobacterium, Angelakisella, and Oscillibacter were associated with day 0, while Ruminococcaceae_UCG_013, Pediococcus, Eubacterium, Bacillus, and Catabacter were associated with day 14. Further investigations are warranted to clarify the influence of ivermectin on chinchillas with parasites infection or in a long term.

Author Contributions

Conceptualization, J.L. and F.Y.; methodology, F.Y., X.M. and L.Y.; investigation, X.M., F.Y., L.Y., Y.Z. and B.L.; project administration, J.L. and B.L.; resources, J.L., B.L. and Y.Z.; validation, H.L. and H.R.; data curation, H.L.; writing—original draft preparation, X.M. and F.Y.; writing—review and editing, J.L., L.Y. and Y.Z.; supervision, J.L.; funding acquisition, F.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by The Talent Fund of China Agricultural University Veterinary Teaching Hospital (Beijing Zhongnongda Veterinary Hospital Co., Ltd.). Award Number: 1051-2221002.

Institutional Review Board Statement

The animal study protocol was approved by the Animal Care and Use Committee of China Agricultural University (protocol code AW82103202-2-1).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are openly available in Figshare at https://doi.org/10.6084/m9.figshare.21972641.v1 (accessed on 29 January 2023).

Conflicts of Interest

The authors declare no competing interest.

References

  1. Patton, J.L.; Pardiñas, U.F.J.; D’Elía, G. Mammals of South America, Volume 2. Rodents; UCP: Chicago, IL, USA, 2015; pp. 765–768. [Google Scholar]
  2. Donnelly, T.M.; Brown, C.J. Guinea pig and chinchilla care and husbandry. Vet. Clin. N. Am. Exot. Anim. Pract. 2004, 7, 351–373. [Google Scholar] [CrossRef] [PubMed]
  3. ESCCAP. ESCCAP Guideline 7: Control of parasites and fungal infections in small pet mammals. ESCCAP 2017, 61–63. Available online: https://www.esccap.org/guidelines/gl7/ (accessed on 17 December 2022).
  4. Artis, D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 2008, 8, 411–420. [Google Scholar] [CrossRef] [PubMed]
  5. Jandhyala, S.M.; Talukdar, R.; Subramanyam, C.; Vuyyuru, H.; Sasikala, M.; Nageshwar Reddy, D. Role of the normal gut microbiota. World J. Gastroenterol. 2015, 21, 8787–8803. [Google Scholar] [CrossRef]
  6. Clemente, J.C.; Ursell, L.K.; Parfrey, L.W.; Knight, R. The impact of the gut microbiota on human health: An integrative view. Cell 2012, 148, 1258–1270. [Google Scholar] [CrossRef] [Green Version]
  7. Morrison, D.J.; Preston, T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 2016, 7, 189–200. [Google Scholar] [CrossRef] [Green Version]
  8. Lange, K.; Buerger, M.; Stallmach, A.; Bruns, T. Effects of antibiotics on gut microbiota. Dig Dis. 2016, 34, 260–268. [Google Scholar] [CrossRef]
  9. Martin, R.J.; Robertson, A.P.; Choudhary, S. Ivermectin: An anthelmintic, an insecticide, and much more. Trends Parasitol. 2021, 37, 48–64. [Google Scholar] [CrossRef]
  10. Foletto, V.R.; Vanz, F.; Gazarini, L.; Stern, C.A.; Tonussi, C.R. Efficacy and security of ivermectin given orally to rats naturally infected with Syphacia spp., Giardia spp. and Hymenolepis nana. Lab. Anim. 2015, 49, 196–200. [Google Scholar] [CrossRef]
  11. Dicks, L.M.T.; Deane, S.M.; Grobbelaar, M.J. Could the COVID-19-driven increased use of ivermectin lead to incidents of imbalanced gut microbiota and dysbiosis? Probiotics Antimicrob. Proteins 2022, 14, 217–223. [Google Scholar] [CrossRef]
  12. He, F.; Zhai, J.; Zhang, L.; Liu, D.; Ma, Y.; Rong, K.; Xu, Y.; Ma, J. Variations in gut microbiota and fecal metabolic phenotype associated with fenbendazole and ivermectin tablets by 16S rRNA gene sequencing and LC/MS-based metabolomics in amur tiger. Biochem. Biophys. Res. Commun. 2018, 499, 447–453. [Google Scholar] [CrossRef]
  13. Schneeberger, P.H.H.; Coulibaly, J.T.; Gueuning, M.; Moser, W.; Coburn, B.; Frey, J.E.; Keiser, J. Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota. Int. J. Parasitol. Drugs Drug Resist. 2018, 8, 372–378. [Google Scholar] [CrossRef]
  14. Bailey, M.T.; Lauber, C.L.; Novotny, L.A.; Goodman, S.D.; Bakaletz, L.O. Immunization with a biofilm-disrupting nontypeable Haemophilus influenzae vaccine antigen did not alter the gut microbiome in chinchillas, unlike oral delivery of a broad-spectrum antibiotic commonly used for otitis media. mSphere 2020, 5, e00296-20. [Google Scholar] [CrossRef] [Green Version]
  15. Cole, J.R.; Wang, Q.; Cardenas, E.; Fish, J.; Chai, B.; Farris, R.J.; Kulam-Syed-Mohideen, A.S.; McGarrell, D.M.; Marsh, T.; Garrity, G.M.; et al. The ribosomal database project: Improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 2009, 37, D141–D145. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. O’Donnell, M.M.; Harris, H.M.B.; Ross, R.P.; O’Toole, P.W. Core fecal microbiota of domesticated herbivorous ruminant, hindgut fermenters, and monogastric animals. Microbiologyopen 2017, 6, e00509. [Google Scholar] [CrossRef] [PubMed]
  17. Peachey, L.E.; Molena, R.A.; Jenkins, T.P.; Di Cesare, A.; Traversa, D.; Hodgkinson, J.E.; Cantacessi, C. The relationships between faecal egg counts and gut microbial composition in UK thoroughbreds infected by cyathostomins. Int. J. Parasitol. 2018, 48, 403–412. [Google Scholar] [CrossRef] [PubMed]
  18. Velasco-Galilea, M.; Piles, M.; Viñas, M.; Rafel, O.; González-Rodríguez, O.; Guivernau, M.; Sanchez, J.P. Rabbit microbiota changes throughout the intestinal tract. Front. Microbiol. 2018, 9, 2144. [Google Scholar] [CrossRef] [PubMed]
  19. Hu, C.; Rzymski, P. Non-photosynthetic melainabacteria (cyanobacteria) in human gut: Characteristics and association with health. Life 2022, 12, 476. [Google Scholar] [CrossRef]
  20. Shepherd, M.L.; Swecker, W.S., Jr.; Jensen, R.V.; Ponder, M.A. Characterization of the fecal bacteria communities of forage-fed horses by pyrosequencing of 16S rRNA V4 gene amplicons. FEMS Microbiol. Lett. 2012, 326, 62–68. [Google Scholar] [CrossRef] [Green Version]
  21. Montes-Carreto, L.M.; Aguirre-Noyola, J.L.; Solís-García, I.A.; Ortega, J.; Martinez-Romero, E.; Guerrero, J.A. Diverse methanogens, bacteria and tannase genes in the feces of the endangered volcano rabbit (Romerolagus diazi). PeerJ 2021, 9, e11942. [Google Scholar] [CrossRef]
  22. Brenner, S.R. Blue-green algae or cyanobacteria in the intestinal micro-flora may produce neurotoxins such as Beta-N-Methylamino-L-Alanine (BMAA) which may be related to development of amyotrophic lateral sclerosis, Alzheimer’s disease and Parkinson-dementia-complex in humans and equine motor neuron disease in horses. Med. Hypotheses 2013, 80, 103. [Google Scholar] [PubMed]
  23. Demay, J.; Bernard, C.; Reinhardt, A.; Marie, B. Natural products from cyanobacteria: Focus on beneficial activities. Mar. Drugs 2019, 17, 320. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Wang, Z.; Li, X.; Zhang, L.; Wu, J.; Zhao, S.; Jiao, T. Effect of oregano oil and cobalt lactate on sheep in vitro digestibility, fermentation characteristics and rumen microbial community. Animals 2022, 12, 118. [Google Scholar] [CrossRef] [PubMed]
  25. Reichardt, N.; Duncan, S.H.; Young, P.; Belenguer, A.; McWilliam Leitch, C.; Scott, K.P.; Flint, H.J.; Louis, P. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J. 2014, 8, 1323–1335. [Google Scholar] [CrossRef] [Green Version]
  26. Yang, C.; Tsedan, G.; Liu, Y.; Hou, F. Shrub coverage alters the rumen bacterial community of yaks (Bos grunniens) grazing in alpine meadows. J. Anim. Sci. Technol. 2020, 62, 504–520. [Google Scholar] [CrossRef]
  27. Xia, G.; Sun, J.; Fan, Y.; Zhao, F.; Ahmed, G.; Jin, Y.; Zhang, Y.; Wang, H. β-Sitosterol attenuates high grain diet-induced inflammatory stress and modifies rumen fermentation and microbiota in sheep. Animals 2020, 10, 171. [Google Scholar] [CrossRef] [Green Version]
  28. Ma, J.; Zhu, Y.; Wang, Z.; Yu, X.; Hu, R.; Wang, X.; Cao, G.; Zou, H.; Shah, A.M.; Peng, Q.; et al. Comparing the bacterial community in the gastrointestinal tracts between growth-retarded and normal yaks on the Qinghai-Tibetan plateau. Front. Microbiol. 2020, 11, 600516. [Google Scholar] [CrossRef]
  29. Li, J.; Sung, C.Y.; Lee, N.; Ni, Y.; Pihlajamäki, J.; Panagiotou, G.; El-Nezami, H. Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proc. Natl. Acad. Sci. USA 2016, 113, E1306–E1315. [Google Scholar] [CrossRef] [Green Version]
  30. Paz, E.A.; Chua, E.G.; Hassan, S.U.; Greeff, J.C.; Palmer, D.G.; Liu, S.; Lamichhane, B.; Sepúlveda, N.; Liu, J.; Tay, C.Y.; et al. Bacterial communities in the gastrointestinal tract segments of helminth-resistant and helminth-susceptible sheep. Anim. Microbiome 2022, 4, 23. [Google Scholar] [CrossRef]
  31. Liao, R.; Xie, X.; Lv, Y.; Dai, J.; Lin, Y.; Zhu, L. Ages of weaning influence the gut microbiota diversity and function in Chongming white goats. Appl. Microbiol. Biotechnol. 2021, 105, 3649–3658. [Google Scholar] [CrossRef]
  32. Du, M.; Yang, C.; Liang, Z.; Zhang, J.; Yang, Y.; Ahmad, A.A.; Yan, P.; Ding, X. Dietary energy levels affect carbohydrate metabolism-related bacteria and improve meat quality in the longissimus thoracis muscle of yak (Bos grunniens). Front. Vet. Sci. 2021, 8, 718036. [Google Scholar] [CrossRef] [PubMed]
  33. Qin, S.; Huang, Z.; Wang, Y.; Pei, L.; Shen, Y. Probiotic potential of Lactobacillus isolated from horses and its therapeutic effect on DSS-induced colitis in mice. Microb. Pathog. 2022, 165, 105216. [Google Scholar] [CrossRef] [PubMed]
  34. Mukherjee, A.; Lordan, C.; Ross, R.P.; Cotter, P.D. Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health. Gut Microbes 2020, 12, 1802866. [Google Scholar] [CrossRef] [PubMed]
  35. Jin, D.X.; Zou, H.W.; Liu, S.Q.; Wang, L.Z.; Xue, B.; Wu, D.; Tian, G.; Cai, J.; Yan, T.H.; Wang, Z.S.; et al. The underlying microbial mechanism of epizootic rabbit enteropathy triggered by a low fiber diet. Sci. Rep. 2018, 8, 12489. [Google Scholar] [CrossRef] [PubMed]
  36. Cutting, S.M. Bacillus probiotics. Food Microbiol. 2011, 28, 214–220. [Google Scholar] [CrossRef]
  37. Zhang, N.; Wang, L.; Wei, Y. Effects of Bacillus pumilus on growth performance, immunological indicators and gut microbiota of mice. J. Anim. Physiol. Anim. Nutr. 2021, 105, 797–805. [Google Scholar] [CrossRef]
  38. Chen, N.; Liu, Y.; Qin, P.; Li, Y.; Ma, D.; Li, J.; Shi, T.; Zhu, Z. Antibacterial activities of Bacillus amyloliquefaciens DQB-1 isolated from the cecum of Dezhou donkeys. J. Equine Vet. Sci. 2021, 102, 103616. [Google Scholar] [CrossRef]
  39. Mayer, J.; Donnelly, T.M. Clinical Veterinary Advisor: Birds and Exotic Pets; Elsevier Saunders: St. Louis, MO, USA, 2013; Available online: https://www.clinvetadvisorexotics.com/index.php (accessed on 17 December 2022).
Vetsci 10 00169 g001 550
Figure 1. The ACE indexes (left) and Simpson indexes (right) of two groups, indicating the richness and diversity change after administration.
Figure 1. The ACE indexes (left) and Simpson indexes (right) of two groups, indicating the richness and diversity change after administration.
Vetsci 10 00169 g001
Vetsci 10 00169 g002 550
Figure 2. (a) The composition of fecal bacterial microbiota in day 0 and day 14 group at the phylum level. (b) The composition of fecal bacterial microbiota in day 0 and day 14 group at the genus level.
Figure 2. (a) The composition of fecal bacterial microbiota in day 0 and day 14 group at the phylum level. (b) The composition of fecal bacterial microbiota in day 0 and day 14 group at the genus level.
Vetsci 10 00169 g002
Vetsci 10 00169 g003 550
Figure 3. LEfSe showed the significantly different bacterial taxa of which the LDA scores were above 2 between day 0 and day 14 group.
Figure 3. LEfSe showed the significantly different bacterial taxa of which the LDA scores were above 2 between day 0 and day 14 group.
Vetsci 10 00169 g003
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ma, X.; Li, J.; Yang, L.; Liu, H.; Zhu, Y.; Ren, H.; Yu, F.; Liu, B. Short Term Effect of Ivermectin on the Bacterial Microbiota from Fecal Samples in Chinchillas (Chinchilla lanigera). Vet. Sci. 2023, 10, 169. https://doi.org/10.3390/vetsci10020169

AMA Style

Ma X, Li J, Yang L, Liu H, Zhu Y, Ren H, Yu F, Liu B. Short Term Effect of Ivermectin on the Bacterial Microbiota from Fecal Samples in Chinchillas (Chinchilla lanigera). Veterinary Sciences. 2023; 10(2):169. https://doi.org/10.3390/vetsci10020169

Chicago/Turabian Style

Ma, Xinyi, Jing Li, Luo Yang, Haoqian Liu, Yiping Zhu, Honglin Ren, Feng Yu, and Bo Liu. 2023. "Short Term Effect of Ivermectin on the Bacterial Microbiota from Fecal Samples in Chinchillas (Chinchilla lanigera)" Veterinary Sciences 10, no. 2: 169. https://doi.org/10.3390/vetsci10020169

APA Style

Ma, X., Li, J., Yang, L., Liu, H., Zhu, Y., Ren, H., Yu, F., & Liu, B. (2023). Short Term Effect of Ivermectin on the Bacterial Microbiota from Fecal Samples in Chinchillas (Chinchilla lanigera). Veterinary Sciences, 10(2), 169. https://doi.org/10.3390/vetsci10020169

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop